| Name: | Candesartan Ethyl Ester Desethyl N2-Cilexetil Analog |
| Catalogue No. | VE007546 |
| CAS No. | N/A |
| Molecular Formula | C33H34N6O6 |
| Molecular Weight | 610.66 g/mol |
| Status | In-Stock |
| IUPAC Name | Ethyl 1-({2'-[2-(1-{[(cyclohexyloxy) carbonyl] oxy} ethyl)-1H-tetrazol-5-yl] biphenyl-4-yl} methyl)-2-hydroxy-1H-benzimidazole-7-carboxylate |
| Description | Candesartan Ethyl Ester Desethyl N2-Cilexetil Analog (CAS No: N/A) Or Ethyl 1-({2'-[2-(1-{[(cyclohexyloxy) carbonyl] oxy} ethyl)-1H-tetrazol-5-yl] biphenyl-4-yl} methyl)-2-hydroxy-1H-benzimidazole-7-carboxylate,Candesartan Ethyl Ester Desethyl N2-Cilexetil Analog is a analog impurity of Candesartan, which lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system. |
| References | Sci-Hub | The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial | 10.1016/s0140-6736(11)60104-9. (2022). Retrieved January 1, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/s0140-6736(11)60104-9 |
